Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Irvin M. Modlin, Giovanni Paganelli et al.|European Journal of Nuclear Medicine and Molecular Imaging|2014Cited by 465
A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastasesSimon Schimmack, Mark Kidd|Epigenetics & Chromatin|2014Cited by 70
Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycinMark Kidd, John R. Murren|Journal of Molecular Endocrinology|2007Cited by 50
The Stimulatory Adenosine Receptor ADORA2B Regulates Serotonin (5-HT) Synthesis and Release in Oxygen-Depleted EC Cells in Inflammatory Bowel DiseaseRikard Damen, Mark Kidd|PLoS ONE|2013Cited by 24
Correction: The Stimulatory Adenosine Receptor ADORA2B Regulates Serotonin (5-HT) Synthesis and Release in Oxygen-Depleted EC Cells in Inflammatory Bowel DiseaseRikard Dammen, Mark Kidd|PLoS ONE|2013Cited by 6